Fibrinolytic Agents Concept

subject area of

• 14 Antithrombotic treatment of cerebrovascular disease  Academic Article
• 15 Side-effects of antithrombotic therapy  Academic Article
• 2 Mechanisms of action of low molecular weight heparins and heparinoids  Academic Article
• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Academic Article
• 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants.  Academic Article
• 6 Mechanism of action of the thrombolytic agents  Academic Article
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease  Academic Article
• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation  Academic Article
• A Patient-Focused Approach to Thrombolytic Use in the Management of Catheter Malfunction  Academic Article
• A Survey of the Use of Empiric Novel Anticoagulants During Investigation of Stroke  Academic Article
• A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement  Academic Article
• A comparison of practice patterns for acute myocardial infarction between hospitals in Canada and India.  Academic Article
• A guide to GRADE guidelines for the readers of JTH  Academic Article
• A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats.  Academic Article
• A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in rats.  Academic Article
• A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo   Academic Article
• A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.  Academic Article
• A novel approach to thrombin inhibition  Academic Article
• A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)  Academic Article
• A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer  Academic Article
• A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.  Academic Article
• ABC of antithrombotic therapy: Valvar heart disease and prosthetic heart valves  Academic Article
• Accelerated Infusion of Streptokinase for the Treatment of Left-Sided Prosthetic Valve Thrombosis: A Randomized Controlled Trial  Academic Article
• Acute coronary syndromes without ST segment elevation  Academic Article
• Acute stroke management.  Academic Article
• Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process.  Academic Article
• Adjunctive Use of Direct Thrombin Inhibitors in Patients Receiving Fibrinolytic Therapy for Acute Myocardial Infarction  Academic Article
• Advances in Antithrombotic Therapy: Novel Agents  Academic Article
• Advances in antithrombotic drug therapy for coronary artery disease  Academic Article
• Altering Vessel Wall Fatty Acid Metabolism: A New Strategy for Antithrombotic Treatment  Academic Article
• An Economic Evaluation of rt-PA Locking Solution in Dialysis Catheters  Academic Article
• An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials  Academic Article
• Animal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs.  Academic Article
• Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial  Academic Article
• Anticoagulants in acute coronary syndromes  Academic Article
• Anticoagulation for prosthetic heart valves: unresolved questions requiring answers.  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation therapy in patients with prosthetic heart valves.  Academic Article
• Antiphospholipid antibodies in critical illness  Academic Article
• Antiphospholipid antibody syndrome  Academic Article
• Antithrombin III deficiency in neonatal respiratory distress syndrome  Academic Article
• Antithrombin-Heparin Covalent Complex: A Possible Alternative to Heparin for Arterial Thrombosis Prevention  Academic Article
• Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation  Academic Article
• Antithrombotic Therapy During Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy Following Heart Valve Replacement  Academic Article
• Antithrombotic Therapy for Atrial Fibrillation  Academic Article
• Antithrombotic Therapy for Cerebrovascular Disorders  Academic Article
• Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Antithrombotic Therapy for VTE Disease  Academic Article
• Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.  Academic Article
• Antithrombotic Therapy for Venous Thromboembolic Disease  Academic Article
• Antithrombotic Therapy in Children*  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Academic Article
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Academic Article
• Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Academic Article
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Academic Article
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Academic Article
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts  Academic Article
• Antithrombotic Therapy in Peripheral Artery Disease  Academic Article
• Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry  Academic Article
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Academic Article
• Antithrombotic agents in coronary artery disease.  Academic Article
• Antithrombotic and Thrombolytic Therapy  Academic Article
• Antithrombotic and Thrombolytic Therapy for Ischemic Stroke  Academic Article
• Antithrombotic and Thrombolytic Therapy: From Evidence to Application  Academic Article
• Antithrombotic drug development for atrial fibrillation: Proceedings, Washington, DC, July 25-27, 2005  Academic Article
• Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey  Academic Article
• Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events  Academic Article
• Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding  Academic Article
• Antithrombotic drugs: part I.  Academic Article
• Antithrombotic drugs: part II.  Academic Article
• Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends  Academic Article
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Academic Article
• Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation  Academic Article
• Antithrombotic therapy in aortic diseases: A narrative review  Academic Article
• Antithrombotic therapy in atrial fibrillation.  Academic Article
• Antithrombotic therapy in children with venous thromboembolism  Academic Article
• Antithrombotic therapy: the expanding role of low molecular weight heparin.  Academic Article
• Antithrombotic treatment for peripheral arterial disease  Academic Article
• Antithrombotics and anticoagulants in coronary syndromes and stroke.  Academic Article
• Apixaban for Extended Treatment of Venous Thromboembolism  Academic Article
• Apixaban in Patients with Atrial Fibrillation  Academic Article
• Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial  Academic Article
• Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial  Academic Article
• Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen  Academic Article
• Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the Antithrombotic Therapy and the Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.  Academic Article
• Applying the Grades of Recommendation for Antithrombotic and Thrombolytic Therapy  Academic Article
• Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients  Academic Article
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Academic Article
• Aspirin for the Primary Prevention of Cardiovascular Events: A systematic review and meta-analysis comparing patients with and without diabetes  Academic Article
• Aspirin resistance: a new independent predictor of vascular events?  Academic Article
• Assessment of antithrombotic drugs ex vivo and in vivo.  Academic Article
• Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH  Academic Article
• BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase  Academic Article
• Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia: A Systematic Review.  Academic Article
• Beyond Unfractionated Heparin and Warfarin: Current and Future Advances  Academic Article
• Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.  Academic Article
• Biological basis and clinical implications of acetylsalicylic acid resistance  Academic Article
• Bivalirudin  Academic Article
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial  Academic Article
• Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency  Academic Article
• Bleeding associated with antithrombotic therapy.  Academic Article
• Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology  Academic Article
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis  Academic Article
• Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism.  Academic Article
• Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism  Academic Article
• Can we optimise treatment of thrombosis?  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter  Academic Article
• Canadian Consensus Conference on Coronary Thrombolysis--1994 update.  Academic Article
• Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits  Academic Article
• Catheter-Directed Thrombolysis for Pulmonary Embolism: Where Do We Stand?  Academic Article
• Central venous catheters: optimizing the suboptimal.  Academic Article
• Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial  Academic Article
• Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk  Academic Article
• Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation  Academic Article
• Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial  Academic Article
• Characterization of the Interactions of Plasminogen and Tissue and Vampire Bat Plasminogen Activators with Fibrinogen, Fibrin, and the Complex of d-Dimer Noncovalently Linked to Fragment E  Academic Article
• Chemical–Physical Characterization of Polyurethane Catheters Modified with a Novel Antithrombin-Heparin Covalent Complex  Academic Article
• Chills and limb pain following administration of low-molecular-weight heparin for treatment of acute venous thromboembolism  Academic Article
• Choice of low molecular weight heparins  Academic Article
• Choice of low molecular weight heparins.  Academic Article
• Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents  Academic Article
• Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia  Academic Article
• Clinical potential of antithrombotic drugs in coronary syndromes  Academic Article
• Combined administration of barbourin–albumin and hirudin–albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta  Academic Article
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Academic Article
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition  Academic Article
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conference Paper
• Comparison of the Efficacy of Pharmacoinvasive Management for ST-Segment Elevation Myocardial Infarction in Smokers Versus Non-Smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction)  Academic Article
• Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism  Academic Article
• Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction  Academic Article
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.  Academic Article
• Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study  Academic Article
• Consultative Hematology: The Pregnant Patient Pregnancy Loss  Academic Article
• Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study.  Academic Article
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Academic Article
• Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis  Academic Article
• Current use of biologicals in thrombosis and haemostasis  Academic Article
• DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE  Academic Article
• Dabigatran Etexilate: Future Directions in Anticoagulant Treatment  Academic Article
• Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial  Academic Article
• Dabigatran-related coagulopathy: when can we assume the effect has “worn off”?  Academic Article
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients  Academic Article
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients  Academic Article
• Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective  Academic Article
• Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis  Academic Article
• Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial  Academic Article
• Determinants of Bleeding Risk in Patients on Antithrombotic and Antifibrinolytic Drugs  Academic Article
• Developing a novel antithrombotic in the academic environment.  Academic Article
• Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation  Academic Article
• Diagnosis and Treatment of Venous Thromboembolism  Academic Article
• Diagnosis of DVT  Academic Article
• Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation  Academic Article
• Direct Thrombin Inhibitors in Cardiac Disease  Academic Article
• Direct thrombin inhibitors  Academic Article
• Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin  Conference Paper
• Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective.  Academic Article
• Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?  Academic Article
• Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.  Academic Article
• Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events  Academic Article
• Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement  Academic Article
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Academic Article
• Drug trials that have influenced our practice in the treatment of venous thromboembolism.  Academic Article
• ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.  Academic Article
• Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure  Academic Article
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Academic Article
• Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect  Academic Article
• Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke: PRoFESS Subgroup Analysis  Academic Article
• Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients  Academic Article
• Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.  Academic Article
• Effect of aspirin on hemostasis and thrombosis.  Academic Article
• Effective, selective and specific inhibition of COX-1 may overcome the “aspirin paradox”  Academic Article
• Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.  Academic Article
• Efficacy and Safety of a Routine Early Invasive Strategy in Relation to Time from Symptom Onset to Fibrinolysis (a Subgroup Analysis of TRANSFER-AMI)  Academic Article
• Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial  Academic Article
• Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial  Academic Article
• Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER ® , RE-COVER™ II, and RE-MEDY™  Academic Article
• Eicosanoids, other fatty acid metabolites and the cardiovascular system: are the present antithrombotic approaches rational?  Academic Article
• Emergence of the Primary Pediatric Stroke Center: Impact of the Thrombolysis in Pediatric Stroke Trial  Academic Article
• Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis.  Academic Article
• Enhancement of the Activity of Optimum Concentrations of Urokinase by the Venom of Echis carinata  Academic Article
• Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non-Q-Wave Myocardial Infarction : Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B Trial  Academic Article
• Evaluation of the use of venous thromboembolism prophylaxis in hospitalised medical patients  Academic Article
• Evidence-Based Management of Anticoagulant Therapy  Academic Article
• Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure.  Academic Article
• Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation  Academic Article
• Executive Summary  Academic Article
• Extended perioperative thromboprophylaxis in patients with cancer. A systematic review.  Academic Article
• Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery – the SAVE-HIP3 study  Academic Article
• Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials  Academic Article
• External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR)  Academic Article
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Academic Article
• Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.  Academic Article
• Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practice.  Academic Article
• Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study.  Academic Article
• Fibrinolytic Poly(dimethyl siloxane) Surfaces  Academic Article
• Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study  Academic Article
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery  Academic Article
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery  Academic Article
• Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery  Academic Article
• Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic SurgeryA Meta-analysis of 4 Randomized Double-blind Studies  Academic Article
• Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy  Academic Article
• Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial  Academic Article
• Further Studies on the Mechanisms for the Antithrombotic Effects of Sulfated Polysaccharides in Rabbits  Academic Article
• GASTROINTESTINAL BLEEDING AFTER ACUTE ISCHEMIC STROKE  Academic Article
• Getting intimate with the venous thrombus  Academic Article
• Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke  Academic Article
• Grades of Recommendation for Antithrombotic Agents  Academic Article
• Grades of Recommendation for Antithrombotic Agents  Academic Article
• Grades of Recommendation for Antithrombotic Agents  Academic Article
• Guided Antithrombotic Therapy: Current Status and Future Research Direction: Report on a National Heart, Lung and Blood Institute Working Group  Academic Article
• Guideline conflict of interest management and methodology heavily impacts on the strength of recommendations: comparison between two iterations of the American College of Chest Physicians Antithrombotic Guidelines.  Academic Article
• Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.  Academic Article
• Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis.  Academic Article
• HEPARIN-INDUCED THROMBOCYTOPENIA: A Ten-Year Retrospective  Academic Article
• Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism  Academic Article
• Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.  Academic Article
• Heparan sulfate: Antithrombotic or not?  Academic Article
• Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate  Academic Article
• Heparin and Low-Molecular-Weight Heparin  Academic Article
• Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases  Academic Article
• Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention  Academic Article
• How can we reduce disagreement among guidelines for venous thromboembolism prevention?  Academic Article
• INHIBITION OF THROMBIN BY HIRUDIN GENETICALLY FUSED TO WILD-TYPE OR MUTANT ANTITHROMBIN  Academic Article
• Idiopathic gangrene in African children.  Academic Article
• Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction  Academic Article
• In acute ischemic stroke, early intraarterial treatment plus usual care improved functional independence  Academic Article
• In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke  Academic Article
• In ischemic stroke, early intraarterial treatment plus alteplase improved reperfusion and functional outcome  Academic Article
• In vivo activity of a new heparinoid.  Academic Article
• In-Vitro Studies with Ancrod (‘Arvin’)  Academic Article
• Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children  Conference Paper
• Increasing Use of Single and Combination Medical Therapy in Patients Hospitalized for Acute Myocardial Infarction in the 21st CenturyA Multinational Perspective  Academic Article
• Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes  Academic Article
• Inhibition of arterial thrombosis and platelet function by nafazatrom  Academic Article
• Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082  Academic Article
• Initial Treatment of Venous Thromboembolism  Academic Article
• Initial treatment of venous thromboembolism.  Academic Article
• International differences in in-hospital revascularization and outcomes following acute myocardial infarction A multilevel analysis of patients in ASSENT-2  Academic Article
• Interruption of Warfarin Anticoagulation for Dental Surgery: Response  Academic Article
• Interventions that potentially limit myocardial infarct size: Overview of clinical trials  Academic Article
• Intra-Arterial Thrombolysis vs. Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis  Academic Article
• Intracranial Aneurysm Rupture Following Intravenous Thrombolysis for Stroke  Academic Article
• Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments  Academic Article
• Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial  Academic Article
• Introduction to the Ninth Edition  Academic Article
• Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question  Academic Article
• Left Atrial Appendage Occlusion Study (LAAOS): A randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention  Academic Article
• Left Atrial Appendage Occlusion Study II (LAAOS II)  Academic Article
• Limited Fibrin Specificity of Tissue-type Plasminogen Activator and Its Potential Link to Bleeding  Academic Article
• Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation  Academic Article
• Long-term outcomes after acute myocardial infarction in countries with different socioeconomic environments: an international prospective cohort study  Academic Article
• Low Anonymous Voting Compliance With the Novel Policy for Managing Conflicts of Interest Implemented in the 9th Version of the American College of Chest Physicians Antithrombotic Guidelines  Academic Article
• Low molecular weight heparins in the treatment of unstable angina.  Academic Article
• Low rates of preventive practices in patients with peripheral vascular disease.  Academic Article
• Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin  Academic Article
• Lysine-PEG-modified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis  Academic Article
• Lysine-derivatized polyurethane as a clot lysing surface: conversion of adsorbed plasminogen to plasmin and clot lysis in vitro  Academic Article
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Academic Article
• Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.  Academic Article
• Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage  Academic Article
• Management of thromboembolic disease in cancer patients.  Academic Article
• Management of unstable angina and myocardial infarction  Academic Article
• Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides  Academic Article
• Medical device-induced thrombosis: what causes it and how can we prevent it?  Academic Article
• Methodology for Antithrombotic and Thrombolytic Therapy Guideline Development  Academic Article
• Methodology for Guideline Development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy  Academic Article
• Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines  Academic Article
• Mimicking the fibrinolytic system on material surfaces  Academic Article
• Missed opportunities for the secondary prevention of cardiovascular disease in Canada  Academic Article
• Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS2 and CHA2DS2-VASc Scores in Patients With Atrial Fibrillation: A Secondary Analysis of the AVERROES Study  Academic Article
• Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation: A Secondary Analysis of the AVERROES Study  Academic Article
• Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction  Academic Article
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Academic Article
• Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound1  Academic Article
• New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management  Conference Paper
• New Anticoagulant Drugs  Academic Article
• New Antithrombotic Agents  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotic Drugs: Potential for Use in Oncology  Academic Article
• New Antithrombotics  Academic Article
• New anticoagulant strategies. Current status and future potential.  Academic Article
• New anticoagulants  Conference Paper
• New antithrombotic agents  Academic Article
• New antithrombotic agents—insights from clinical trials  Academic Article
• New oral anticoagulants in atrial fibrillation  Academic Article
• New-onset chest pain and palpitation  Academic Article
• Non-ST segment elevation acute coronary syndromes: A simplified risk-oriented algorithm  Academic Article
• Non-traumatic vascular emergencies: imaging and intervention in acute arterial conditions.  Academic Article
• Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy  Academic Article
• Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.  Academic Article
• Observations in anticoagulant and thrombolytic therapy in pulmonary embolism  Academic Article
• Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage  Academic Article
• Optimization of Treatment for Venous Thromboembolism and Prevention of Recurrences  Academic Article
• Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement  Academic Article
• Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia  Conference Paper
• Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours  Academic Article
• Overexpression of the multidrug resistance protein-4 transporter in patients undergoing coronary artery bypass graft surgery a cause of aspirin resistance?  Academic Article
• Overview of the clinical results of pentasaccharide in major orthopedic surgery.  Academic Article
• PLATELET SUPPRESSIVE THERAPY  Academic Article
• PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.  Academic Article
• PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan  Academic Article
• Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study  Academic Article
• Parenteral Anticoagulants  Academic Article
• Part 5: Acute Coronary Syndromes  Academic Article
• Part 9: Acute Coronary Syndromes  Academic Article
• Part 9: Acute Coronary Syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations  Academic Article
• Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study  Academic Article
• Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: Fundamental principles and the contribution of platelets and thrombin  Academic Article
• Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review  Academic Article
• Pediatric Stroke Initiatives and Preliminary Studies: What Is Known and What Is Needed?  Conference Paper
• Perioperative Aspirin for Prevention of Venous Thromboembolism: The PeriOperative ISchemia Evaluation-2 Trial and a Pooled Analysis of the Randomized Trials.  Academic Article
• Perioperative Management of Antithrombotic Therapy  Academic Article
• Perioperative management of antithrombotic therapy.  Academic Article
• Perioperative management of antithrombotic therapy: lifting the fog  Academic Article
• Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy  Academic Article
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Academic Article
• Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials.  Academic Article
• Pharmacologic tools to reduce bleeding in surgery.  Academic Article
• Pharmacological Actions of Sulodexide  Academic Article
• Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis  Academic Article
• Plasmin accelerates platelet-dependent prothrombinase formation without activating the platelets  Academic Article
• Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.  Academic Article
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelet-inhibiting drugs iee parts).  Academic Article
• Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).  Academic Article
• Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).  Academic Article
• Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem  Academic Article
• Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial  Academic Article
• Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison  Academic Article
• Potential antidotes for reversal of old and new oral anticoagulants  Academic Article
• Practical Model-Based Dose Finding in Early-Phase Clinical Trials: Optimizing Tissue Plasminogen Activator Dose for Treatment of Ischemic Stroke in Children  Academic Article
• Pre Admission Antithrombotics are Associated with Improved Outcomes following Ischaemic Stroke: A Cohort from the Registry of the Canadian Stroke Network  Academic Article
• Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study  Academic Article
• Predicting tissue plasminogen activator use and success in in-center hemodialysis patients  Academic Article
• Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial.  Academic Article
• Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts  Academic Article
• Preventing thromboembolic complications in older orthopaedic surgery patients: interventions and outcomes.  Academic Article
• Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.  Academic Article
• Prevention and treatment of venous thromboembolism during pregnancy  Academic Article
• Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator  Academic Article
• Prevention of Thrombus Growth by Antithrombin III-Dependent and Two Direct Thrombin Inhibitors in Rabbits: Implications for Antithrombotic Therapy  Academic Article
• Prevention of VTE in Nonsurgical Patients  Academic Article
• Prevention of VTE in Orthopedic Surgery Patients  Academic Article
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Academic Article
• Prevention of thrombosis in antiphospholipid syndrome  Academic Article
• Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents  Academic Article
• Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)  Academic Article
• Primary and Secondary Prevention of Cardiovascular Disease  Academic Article
• Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation : Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) Study  Academic Article
• Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness  Academic Article
• Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite “Therapeutic” Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding  Academic Article
• Pros and cons of catheter lock solutions  Academic Article
• Protein-Resistant and Fibrinolytic Polyurethane Surfaces  Academic Article
• Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial  Academic Article
• Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)  Academic Article
• Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.  Academic Article
• Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.  Academic Article
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Academic Article
• Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)  Academic Article
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Academic Article
• Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial  Academic Article
• Recommendations for prophylaxis of pregnancy-related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines: a rebuttal  Academic Article
• Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty  Academic Article
• Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins  Academic Article
• Reflecting on Eight Editions of the American College of Chest Physicians Antithrombotic Guidelines  Academic Article
• Regression Analysis with a Misclassified Covariate from a Current Status Observation Scheme  Academic Article
• Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery  Academic Article
• Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin  Academic Article
• Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors  Academic Article
• Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials.  Academic Article
• Response to Dr Junqueira.  Academic Article
• Response to “Effect of Tissue Plasminogen Activator Dose and Interval on Stroke Severity”  Academic Article
• Response.  Academic Article
• Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF  Academic Article
• Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin  Academic Article
• Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding  Academic Article
• Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry  Academic Article
• Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation  Academic Article
• Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis  Academic Article
• Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES  Academic Article
• Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty  Academic Article
• Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies  Academic Article
• Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction  Academic Article
• Routine Heparin for Patients with Cancer? One Answer, More Questions  Academic Article
• Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.  Academic Article
• Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.  Academic Article
• Rules of evidence and clinical recommendations on the use of antithrombotic agents.  Academic Article
• STATIN DRUGS AND DIETARY ISOPRENOIDS AS ANTITHROMBOTIC AGENTS  Academic Article
• SUBOPTIMAL PREVENTIVE PRACTICES IN PATIENTS WITH CAROTID AND PERIPHERAL VASCULAR OCCLUSIVE DISEASE IN A TERTIARY REFERRAL SETTING  Academic Article
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Academic Article
• Safety of thrombolysis in cerebral venous thrombosis. A systematic review of the literature.  Academic Article
• Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: Intracranial hemorrhage in trials of bolus thrombolytic therapy.  Academic Article
• Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer  Academic Article
• Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE  Academic Article
• Setting a standard for venous thromboembolism prophylaxis.  Academic Article
• Sex differences in the antithrombotic effects of aspirin.  Academic Article
• Sex related differences in platelet function: the effect of aspirin.  Academic Article
• Sex-Based Differences in the Effect of Intra-Arterial Treatment of Stroke: Analysis of the PROACT-2 Study  Academic Article
• Sex-related differences in the efficacy of acetylsalicylic acid (ASA): The absorption of ASA and its effect on collagen-induced thromboxane B2 generation  Academic Article
• Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?  Academic Article
• Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?  Academic Article
• Significant association with location of central venous line placement and risk of venous thrombosis in children  Academic Article
• Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST)  Academic Article
• Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group  Academic Article
• State of the Art-A Journey through the World of Antithrombotic Therapy  Academic Article
• State-of-the-Art-Review : Statins Induce Hypothrombotic States?  Academic Article
• Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE)  Academic Article
• Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease  Academic Article
• Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST)  Academic Article
• Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program  Academic Article
• Studies on the medical treatment of deep vein thrombosis.  Academic Article
• Successors to heparin: new antithrombotic agents.  Academic Article
• Superior mesenteric vein thrombosis after the Whipple procedure: an aggressive, combined treatment approach.  Academic Article
• Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points  Academic Article
• Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction  Academic Article
• Systematic lower limb phlebography in acute spinal cord injury in 147 patients  Academic Article
• THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.  Academic Article
• The Antithrombotic Properties of Human Prothrombin Fragment 1.2 in Mice  Academic Article
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Academic Article
• The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro  Academic Article
• The Influence of Age on in vitro Plasmin Generation in the Presence of Fibrin Monomer  Academic Article
• The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War?  Academic Article
• The Perioperative Management of Antithrombotic Therapy  Academic Article
• The Primary and Secondary Prevention of Coronary Artery Disease  Academic Article
• The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model  Academic Article
• The consensus report: is it ever the last word?  Academic Article
• The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial  Academic Article
• The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study  Academic Article
• The emerging role of low-molecular-weight heparin in cardiovascular medicine  Academic Article
• The evolving role of direct thrombin inhibitors in acute coronary syndromes.  Academic Article
• The optimal antithrombotic dose of aspirin  Academic Article
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Academic Article
• The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits.  Academic Article
• The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.  Academic Article
• The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality  Academic Article
• The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial  Academic Article
• The role of platelets and platelet inhibition in acute myocardial infarction  Academic Article
• The safety of antithrombotic therapy during pregnancy  Academic Article
• The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians.  Academic Article
• The status of new anticoagulants  Academic Article
• The treatment of venous thromboembolism.  Academic Article
• The use of alteplase to restore patency of central venous lines in pediatric patients: A cohort study  Academic Article
• Theoretical and Practical Aspects of Thrombolytic Therapy  Academic Article
• Therapy of deep vein thrombosis.  Academic Article
• Thrombin and Antithrombotics  Academic Article
• Thrombin structure and function: why thrombin is the primary target for antithrombotics.  Academic Article
• Thromboembolic Disease and Antithrombotic Therapy in Newborns  Academic Article
• Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism: A Meta-Analysis of the Randomized Controlled Trials  Academic Article
• Thrombolysis Despite Recent Stroke: A Case Series  Academic Article
• Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.  Academic Article
• Thrombolysis in Pediatric Stroke Study  Academic Article
• Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin  Academic Article
• Thrombolytic Therapy and Fatal Pulmonary Emboli  Academic Article
• Thrombolytic therapy for venous thromboembolism. Complications and contraindications.  Academic Article
• Thromboprophylaxis in medical–surgical critically ill patients  Academic Article
• Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial  Academic Article
• Thrombosis and anticoagulation.  Academic Article
• Thrombosis in Children  Academic Article
• Thrombosis.  Academic Article
• Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial  Academic Article
• Tissue Plasminogen Activator Overdose in Acute Ischemic Stroke Patients Linked to Poorer Functional Outcomes  Academic Article
• Transforming the scientific, health care, and sociopolitical culture of an entire country through clinical research: The story of GISSI  Academic Article
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment for acute myocardial infarction: Overview of randomized clinical trials  Academic Article
• Treatment of Deep-Vein Thrombosis  Academic Article
• Treatment of Venous Thromboembolism  Academic Article
• Treatment of Venous Thromboembolism  Academic Article
• Treatment of acute iliofemoral deep vein thrombosis  Academic Article
• Treatment of acute ischemic stroke: from fibrinolysis to neurointervention  Academic Article
• Treatment with novel oral anticoagulants: indications, efficacy and risks.  Academic Article
• Trifecta or Triple Threat? The Challenge of Post-PCI Management in Patients Receiving Chronic Oral Anticoagulant Therapy  Academic Article
• Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents  Academic Article
• Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism  Academic Article
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis  Academic Article
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels  Academic Article
• Unstable Angina and Non-ST-Elevation Myocardial Infarction: Initial Antithrombotic Therapy and Early Invasive Strategy  Academic Article
• Unstable angina.  Academic Article
• Unstable angina.  Academic Article
• Update on heparin: what do we need to know?  Academic Article
• Updates in thrombosis in pediatrics: where are we after 20 years?  Academic Article
• Urgent Clinical Challenges in Children With Ischemic Stroke: Analysis of 1065 Patients From the 1-800-NOCLOTS Pediatric Stroke Telephone Consultation Service  Academic Article
• Urokinase Therapy: Dosage Schedules and Coagulant Side Effects  Academic Article
• Use of Antithrombotic Agents During Pregnancy  Academic Article
• Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study  Academic Article
• Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease undergoing surgery [corrected].  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGIC SURGERY  Academic Article
• VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Academic Article
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Academic Article
• Varied opinions on thrombolysis for venous thromboembolism in infants and children: Findings from a survey of pediatric hematology-oncology specialists  Academic Article
• Vascular viewpoint  Academic Article
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014  Academic Article
• Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Academic Article
• Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients  Academic Article
• Venous thromboembolism and bleeding in a community setting  Academic Article
• Venous thromboembolism in critical illness in a community intensive care unit  Academic Article
• Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.  Academic Article
• Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review  Academic Article
• Video laparoscopic surgery: is out-of-hospital thromboprophylaxis necessary?  Academic Article
• What is the role for antithrombotics in cancer care? Interactive session with panel discussion.  Academic Article
• Which antithrombotic to use during PCI?  Academic Article
• Women’s Values and Preferences for Thromboprophylaxis during Pregnancy: A Comparison of Direct-choice and Decision Analysis using Patient Specific Utilities  Academic Article
• XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy  Academic Article
• [Antithrombotic treatment of atrial fibrillation].  Academic Article